In addition, icariin was reported to enhance cytotoxicity of doxorubin in the human osteosarcoma doxorubicin (DOX)-resistant MG-63/DOX cell line through down-regulation of PI3K-Akt pathway [65]. This evidence concerns the gene AKT1 and osteosarcoma.